YAKIMA, WA and NAPLES, FL — (Marketwired) — 08/21/13 — , the leader in business intelligence for ICD-10 and beyond, announced today that the , a professional healthcare IT quality assurance and consulting firm, will be utilizing its VitalSigns tool as part of the Lott QA Group-s Testing Services, the most widely used methodology across the industry today for ICD-10 end-to-end testing.
VitalSigns is the only claims auditing and ICD-10 financial risk assessment tool that uses TrueShift modeling, utilizing data mined from thousands of natively-coded ICD-10 charts.
As part of the partnership, the Lott QA Group will use VitalSigns in client engagements to natively ten-code claims from medical records to determine documentation and coding opportunities and pinpoint a facility-s specific revenue risks associated with DRG shift.
“The Lott QA Group is leading the industry in collaborative, national testing and known for its asynchronous methodology. Our partnership with VitalWare allows us to analyze our clients- claims at a much deeper level so that they can see which of their specific DRGs shift, why they shift, and the financial impact of that shift,” said Juliet Santos, Executive VP of Strategy and Business Development at the Lott QA Group. “VitalSigns is a powerful, yet nimble application that creates -aha- moments for hospitals analyzing ICD-10 financial risk.”
“The Lott QA Group-s services are more important than ever in light of CMS-s announcement that they would not be participating in ICD-10 end-to-end testing. Providers, payers, clearinghouses and other involved entities have no other collaborative testing model to utilize in performing the crucial process of validating accurate claims creation, transmission, adjudication, and payment. VitalWare recognizes the need for this model and recommends that all organizations participate in this program,” said Kerry Martin, CEO and Founder of VitalWare. “Lott QA Group is recognized as the national standard for the , and VitalWare is proud to be recognized and selected as a critical part of their testing platform.”
“VitalSigns has proven to be a rapid method for assessing true financial risk and uncovering documentation and coding risks in ICD-10. By partnering with VitalWare, we are enhancing our customer-s ROI while helping them mitigate their financial risks,” states Mark Lott, CEO and founder of the Lott QA Group.
VitalSigns, VitalWare-s Auditing and ICD-10 Risk Assessment tool, assists providers and consultant groups in the auditing and ten-coding of patient charts.
Through natively ten-coding thousands of records with the VitalSigns application, VitalWare, its clients and partners have confirmed that the only tangible way to identify true reimbursement risk under ICD-10 is to utilize the documentation present in a chart and recode it.
According to Martin, “Relying on code to code translation, without considering the medical record, will leave providers vulnerable to false security when assessing ICD-10 financial risk.”
VitalWare leads the market in transforming healthcare intelligence into useful and actionable information, thereby allowing their clients to focus their time and resources on core business. Headquartered in Washington State, VitalWare was established to help organizations with the overwhelming task of navigating the many regulatory changes taking place in today-s healthcare environment. For more information visit , email , or call 855.464.2310.
The Lott QA Group is a professional healthcare IT quality assurance and consulting firm delivering advanced testing solutions in healthcare, HIPAA EDI and ICD-10 clinical testing life cycles. The Lott Method is the most widely used end-to-end testing process in the country and is currently in use at both the state and national levels.
Leslee Paganelli
(855) 464-2310 ext 650
You must be logged in to post a comment Login